16.46

0.86% 0.14

After Hours: 16.45 -0.01 -0.06%

Teva Pharmaceutical Industries Ltd Adr (TEVA)

Overview News Price History Option Chain Financials Why TEVA Down? Discussions Forecast Stock Split Dividend History

Teva Pharmaceutical Industries Ltd Adr stock is traded at $16.46, with a volume of 8.39M. It is up +0.86% in the last 24 hours and down -7.16% over the past month. Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Previous Close:

$16.32

Open:

$16.22

24h Volume:

8.39M

Relative Volume:

0.76

Market Cap:

$18.86B

Revenue:

$16.54B

Net Income/Loss:

$-1.64B

P/E Ratio:

-11.35

EPS:

-1.45

Net Cash Flow:

$749.00M

1W Performance:

-1.67%

1M Performance:

-7.16%

6M Performance:

-12.77%

1Y Performance:

+25.17%

1-Day Range:

$16.06

$16.46

1-Week Range:

$16.06

$17.13

52-Week Range:

$12.51

$22.80

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile

Name

Teva Pharmaceutical Industries Ltd Adr

Sector

Healthcare (1168)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

972 (3) 914-8213

Address

TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV

Employee

35,686

Twitter

@TevaUSA

Next Earnings Date

2025-01-29

Latest SEC Filings

TEVA's Discussions on Twitter

Compare TEVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TEVA Teva Pharmaceutical Industries Ltd Adr	16.46	18.86B	16.54B	-1.64B	749.00M	-1.45
ZTS Zoetis Inc	167.24	74.89B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.18	46.03B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.41	45.69B	30.25B	1.37B	5.08B	0.4257
ITCI Intra Cellular Therapies Inc	128.20	13.63B	612.78M	-86.37M	-62.91M	-0.87

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-10-24	Upgrade	Argus	Hold → Buy
Mar-08-24	Upgrade	JP Morgan	Underweight → Neutral
Feb-12-24	Upgrade	Piper Sandler	Neutral → Overweight
Jan-23-24	Upgrade	Jefferies	Hold → Buy
Jan-03-24	Upgrade	Piper Sandler	Underweight → Neutral
Dec-18-23	Initiated	HSBC Securities	Buy
Nov-27-23	Upgrade	UBS	Neutral → Buy
Jul-06-23	Upgrade	UBS	Sell → Neutral
May-25-23	Initiated	Morgan Stanley	Equal-Weight
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy
Jun-14-22	Resumed	UBS	Neutral
May-17-22	Upgrade	BofA Securities	Underperform → Neutral
May-04-22	Downgrade	Piper Sandler	Neutral → Underweight
Apr-05-22	Upgrade	Barclays	Equal Weight → Overweight
Mar-25-22	Upgrade	Bernstein	Mkt Perform → Outperform
Jan-27-22	Downgrade	Argus	Buy → Hold
Oct-28-21	Downgrade	Raymond James	Outperform → Mkt Perform
May-04-21	Downgrade	UBS	Buy → Neutral
Apr-07-21	Resumed	RBC Capital Mkts	Sector Perform
Nov-25-20	Initiated	Oppenheimer	Perform
Aug-06-20	Upgrade	Barclays	Underweight → Equal Weight
Jul-27-20	Resumed	Goldman	Neutral
Jun-01-20	Upgrade	SunTrust	Hold → Buy
Apr-24-20	Resumed	Citigroup	Neutral
Apr-06-20	Upgrade	UBS	Neutral → Buy
Feb-24-20	Downgrade	Edward Jones	Hold → Sell
Nov-12-19	Upgrade	JP Morgan	Underweight → Neutral
Oct-17-19	Upgrade	Gabelli & Co	Hold → Buy
Aug-07-19	Downgrade	Evercore ISI	Outperform → In-line
Jul-19-19	Initiated	Wolfe Research	Peer Perform
Jul-15-19	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jul-10-19	Resumed	Credit Suisse	Neutral
Jul-05-19	Upgrade	Argus	Hold → Buy
Jun-11-19	Initiated	Barclays	Underweight
Jun-03-19	Upgrade	Oppenheimer	Perform → Outperform
May-30-19	Downgrade	BofA/Merrill	Buy → Underperform
May-28-19	Downgrade	UBS	Buy → Neutral
Mar-20-19	Initiated	SunTrust	Hold
Mar-07-19	Resumed	UBS	Buy

View All

Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Latest News

Feb 27, 2025

Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025

Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News

Feb 27, 2025

Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise

Feb 27, 2025

Should investors be concerned about Cantaloupe Inc (CTLP)? - US Post News

Feb 27, 2025

2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals - GlobeNewswire Inc.

Feb 27, 2025

Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle

Feb 11, 2025

FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle

Feb 11, 2025

Has Hesai Group Sponsored ADR (HSAI) Outpaced Other Auto-Tires-Trucks Stocks This Year? - Yahoo Finance

Feb 11, 2025

Recent Insider Activity Could Benefit Dover Corp (DOV) - Knox Daily

Feb 11, 2025

Analyzing Northern Trust Corp (NTRS) After Recent Trading Activity - Knox Daily

Feb 11, 2025

Understanding the Risks of Investing in QuinStreet Inc (QNST) - Knox Daily

Feb 11, 2025

Feb 10, 2025

why Teva- Pharmaceutical Industries Ltd. ADR [TEVA] is a Good Choice for Investors After New Price Target of $24.71 - The DBT News

Feb 10, 2025

fuboTV Inc [FUBO] is 213.49% higher this YTD. Is it still time to buy? - The DBT News

Feb 10, 2025